加拿大皇家银行:重申Avidity Biosciences评级

证券之星
22 Jan

加拿大皇家银行:重申avidity biosciences(RNA.US)评级,由优于大市调整至优于大市评级,目标价由67.00美元调整至67.00美元。Avidity Biosciences(RNA.US)公司简介:Avidity Biosciences Inc是一家生物技术公司。该公司开发新型抗体寡核苷酸偶联疗法,旨在克服当前寡核苷酸疗法的局限性,以治疗多种严重疾病。其产品AOC1001旨在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10